Phase II Data On E7389, Potential New Therapy For The Treatment Of Breast Cancer
10th Dec 2005, 17:22 GMT
Researchers today presented preliminary safety and efficacy data for E7389 in the treatment of advanced, refractory breast cancer during the San Antonio Breast Cancer Symposium. E7389 is a synthetic analog of halichondrin B (HB), which is a natural product shown in preclinical studies to have highly potent anti-cancer activity in vitro and in vivo... click link for more info.
Phase II Data On E7389, Potential New Therapy For The Treatment Of Breast Cancer related news:
- Eisai Announces Phase II Data on E7389, a Potential New Therapy for the Treatment of Breast Cancer — PR Newswire: All Releases
- Kosan Initiates Phase II Clinical Trial of KOS-953 in Combination With Herceptin for Treatment of Metastatic Breast Cancer — Radiology News from StratCenter.com
- Marine Sponge Molecule Is Model For Novel Anti-Tubulin Agent, Eisai Medical Research Inc — Medical News Today RSS/XML Feed
- New Clinical Data Show Dramatic Benefits of Femara for Women with Breast Cancer Even After Prolonged Period of No Anti-Cancer Treatment — Mammography News from StratCenter.com
- New clinical data shows dramatic benefits of Femara� for women with breast cancer even after prolonged period of no anti-cancer treatment — WebWire - Recent Headlines
- GSK Starts Tykerb Trial In Patients With ErbB2-Overexpressing Breast Cancer Brain Metastasis Following Herceptin And Cranial Radiotherapy — Medical News Today RSS/XML Feed
- Breast cancer drug cuts death risk — the Mail online | Health
- Cytokinetics Announces Presentation of Ispinesib Data at San Antonio Breast Cancer Symposium — Mammography News from StratCenter.com
- Breast cancer treatment changing — The Cancer Blog
- Survival Benefit For Arimidex™ In Early Breast Cancer — Medical News Today RSS/XML Feed
Latest news from Medical News Today RSS/XML Feed:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes